Dietary Intervention Study in Children (DISC) - Catalog
-
Name
Dietary Intervention Study in Children (DISC)
-
Accession Number
HLB00400524a
-
Acronym
DISC
-
Related studies(DISC06) Dietary Intervention Study in Children Follow-Up Study (DISC06)
-
BSI Study IDs
DIS
-
Is public use dataset
False
-
Keywords
-
Ingestion StatusReleased
-
Has Study Datasets
True
-
Has Specimens
True
-
Specimen ID TypeCoded
-
Study Website
-
The Framingham Heart Study Group requires that the requestor must obtain full or expedited IRB/Ethics Committee review and approval to obtain these data. Waivers or a determination that the research is exempt from ethical regulations do not suffice.
False
-
Clinical Trial URLs
-
Study typeClinical Trial
-
Collection TypeOpen BioLINCC Study
-
Cohort typePediatric
-
Interventions
Behavioral: diet, fat-restricted
-
Study Open Date (Data)
2009-10-01
-
Study Open Date (Specimens)
2012-08-31
-
Date materials available
2008-10-13
-
Last updated
2005-06-23
-
Study period
1986-1999
-
Study Contacts
-
NHLBI Division
DCVS
-
ClassificationHeart
-
HIV study classificationnon-HIV
-
COVID study classificationnon-COVID
-
Pre-Website # of Specimens Shipped
1620
-
# of Returned Specimens
0
-
Primary Publication URLs
-
Commercial use data restrictionsNo
-
Data restrictions based on area of researchNo
-
Commercial use specimen restrictionsNo
-
Non-genetic use specimen restrictions based on area of useNo
-
Genetic use of specimens allowed?Yes
-
Genetic use area of research restrictionsNo
-
Specific Consent Restrictions
None.
-
ConditionsCardiovascular Diseases
Heart Diseases
Hypercholesterolemia
-
Objectives
The Dietary Intervention Study in Children (DISC) trial was initiated in 1987 and sought to evaluate the efficacy and safety of a lipid lowering diet in 8 to 10 year old children after at least 3 years of followup. The primary efficacy outcome was low-density lipoprotein (LDL) cholesterol. Secondary efficacy outcomes were total cholesterol, high-density lipoprotein (HDL), cholesterol, and triglycerides. Primary safety outcomes were height and serum ferritin. Secondary safety outcomes included serum zinc, folate, retinol, and albumin. The trial was extended, with continuation of the intervention, albeit at a diminished intensity, to follow the children for an additional 4 years, resulting in a mean of 7.4 years of total follow-up, when the participants were on average 17 years old.
-
Background
A growing body of evidence suggests that atherosclerosis is a long term process that may begin early in childhood. Autopsy studies have revealed coronary fatty streaks in obese children, and other studies have shown that blood cholesterol levels show a fairly high correlation as children age into young adults. Familial clustering of lipid levels provide further rationale for intervention studies aimed at reducing cholesterol levels in children. Previous studies have demonstrated the efficacy of dietary interventions in adults in reducing blood cholesterol levels; however, the safety and efficacy of dietary interventions in growing children were less clear, and previous studies were only short-term interventions.
-
Participants
The DISC study was a multicenter, randomized controlled trial that enrolled 663 prepubertal children aged 8 to 10 years who had elevated LDL-cholesterol levels (80th-98th percentile based on age-gender distributions from the Lipid Research Clinics). The children were assigned at random to an intervention or usual care group. Fifty-five percent of the participants were male. The intervention group attended a series of group and individual sessions where the children and their families were counseled to follow a diet containing 28 percent of calories as total fat, less than 8 percent of calories from saturated fat, dietary cholesterol intake less than 75 mg/1000 kcal, and up to 9% of calories from polyunsaturated fat. The diets were designed to meet nutritional requirements of growing children. The usual care group was provided a packet of educational publications on heart-healthy eating that were generally available to the public. The primary endpoint was change in LDL-cholesterol after three years of followup, and subsequently after 7 years of follow-up.
-
Design
-
Conclusions
After three years of followup, LDL cholesterol decreased by an average of 15.4 mg/dL in the intervention group and 11.9 mg/dL in the usual care group. This difference of 3.3 mg/dL (adjusted for baseline levels and gender) was significant (p=0.02). There were no significant differences between the two groups in adjusted mean height or serum ferritin. There were no significant differences in secondary safety measures as well. (JAMA, 1995; 273(18):1429-35). After 7 years of followup, the difference in LDL-cholesterol between the two treatment groups decreased to 2.0 mg/dL, which was no longer significant. There continued to be no significant differences in an adverse direction in primary or secondary safety measures. (Pediatrics, 2001;107(2):256-264).
-
Disease classification
-
Publications
-
Mat typesSerum
-
Network
The study population available in BioLINCC study data may be lower than total study enrollment due to Informed Consent restrictions and other factors.
-
Subjects
Intervention: 334
Usual care: 329
Last Modified: April 5, 2024, 3:56 p.m. -
Age
Intervention Usual Care All N % N % N % 8 81 24.25 79 24.01 160 24.13 9 169 50.60 163 49.54 332 50.08 10 84 25.15 87 26.44 171 25.79
Last Modified: March 24, 2025, 9:54 a.m. -
Sex
Intervention Usual Care All N % N % N % Male 179 53.59 183 55.62 362 54.60 Female 155 46.41 146 44.38 301 45.40
Last Modified: March 24, 2025, 9:54 a.m. -
Race
Intervention Usual Care All N % N % N % White 289 86.53 285 86.63 574 86.58 Black 25 7.49 31 9.42 56 8.45 Other 20 5.99 13 3.95 33 4.98
Last Modified: March 24, 2025, 9:54 a.m.
Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3.0 of the BioLINCC Handbook describes the components of the review process.
-
Material Types
-
General Freeze/Thaw Status
-
Visits (Vials)
10/22/2019
Serum Total Screening Visit 1 976 976 Screening Visit 2 1,756 1,756 Baseline 9 9 Intervention Visit 254 254 Month 6 276 276 Month 12 1,417 1,417 Month 27 1 1 Month 36 3,602 3,602 Month 37 1,779 1,779 Month 48 542 542 Year 5 1,858 1,858 Year 6 4 4 Year 7 1,128 1,128 Final Visit 1 3,263 3,263 Final Visit 2 (Repeat) 91 91 Unknown 3 3
Last Modified: March 24, 2025, 9:54 a.m. -
Visits (Subjects)
10/22/2019
Serum Total number of subjects Average volume (ml) per subject Screening Visit 1 408 1.42 Screening Visit 2 638 1.53 Baseline 7 8.14 Intervention Visit 83 6.08 Month 6 105 1.19 Month 12 507 1.33 Month 27 1 2.00 Month 36 599 6.77 Month 37 472 2.22 Month 48 87 3.74 Year 5 446 2.53 Year 6 1 6.10 Year 7 229 3.40 Final Visit 1 554 3.91 Final Visit 2 (Repeat) 45 1.08 Unknown 1 3.00
Last Modified: March 24, 2025, 9:54 a.m.